Aemetis, Inc (NASDAQ:AMTX – Get Free Report) saw some unusual options trading activity on Monday. Stock traders purchased 6,674 call options on the stock. This represents an increase of approximately 316% compared to the typical volume of 1,605 call options.
Analyst Ratings Changes
Several analysts have recently weighed in on the company. Weiss Ratings reissued a “sell (e+)” rating on shares of Aemetis in a report on Friday, July 17th. Wall Street Zen raised Aemetis from a “sell” rating to a “hold” rating in a research report on Saturday, August 22nd. One analyst has rated the stock with a Buy rating and one has given a Sell rating to the stock. According to data from MarketBeat, Aemetis presently has an average rating of “Hold” and an average target price of $11.88.
Read Our Latest Analysis on Aemetis
Aemetis Stock Up 8.7%
Aemetis (NASDAQ:AMTX – Get Free Report) last posted its quarterly earnings data on Thursday, August 6th. The specialty chemicals company reported ($0.13) EPS for the quarter, beating analysts’ consensus estimates of ($0.29) by $0.16. The business had revenue of $62.70 million during the quarter, compared to analyst estimates of $67.69 million. Research analysts forecast that Aemetis will post -0.89 EPS for the current fiscal year.
Hedge Funds Weigh In On Aemetis
Institutional investors have recently added to or reduced their stakes in the stock. J. Derek Lewis & Associates Inc. purchased a new stake in Aemetis during the 4th quarter valued at approximately $322,000. Bank of New York Mellon Corp purchased a new position in shares of Aemetis in the 2nd quarter valued at approximately $283,000. Bank of America Corp DE increased its holdings in shares of Aemetis by 148.3% in the first quarter. Bank of America Corp DE now owns 101,486 shares of the specialty chemicals company’s stock valued at $324,000 after purchasing an additional 60,611 shares during the period. Renaissance Technologies LLC acquired a new position in shares of Aemetis in the first quarter valued at approximately $272,000. Finally, Caitong International Asset Management Co. Ltd acquired a new position in shares of Aemetis in the fourth quarter valued at approximately $115,000. Institutional investors and hedge funds own 27.02% of the company’s stock.
About Aemetis
Aemetis, Inc is a renewable fuels and biochemicals company focused on developing and operating technologies that reduce greenhouse gas emissions. Its activities include the production of renewable natural gas, renewable fuels, and other low-carbon products derived from agricultural and organic waste.
The company’s Aemetis Biogas business develops and operates dairy-waste digesters and related infrastructure in California’s Central Valley. These systems capture methane from dairy manure and convert it into renewable natural gas for transportation and other energy applications.
Further Reading
- Five stocks we like better than Aemetis
- 3 Healthcare Stocks Showing Why the Sector Still Has Momentum
- Akamai’s Anthropic Deal Puts $5.5 Billion Behind Its Edge AI Pivot
- 3 Stocks Under the Microscope After Large Insider Sales
- The Nasdaq Nears a Major Breakout: 5 Tech ETFs to Play the Move
Receive News & Ratings for Aemetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aemetis and related companies with MarketBeat.com's FREE daily email newsletter.
